Lobbying Relationship

Client

Fresenius Kabi USA LLC

More records

Lobbying firm

Fresenius Kabi USA LLC

More records

  • Pharmaceutical supply chain and API procurement, Global drug shortages, Tax reform
  • Rebate reform, any willing pharmacy, PBMs, IRA Medicare Direct Negotiation, DIR fees
  • IRA, Part D redesign, rebates, AMP CAP, inflationary penalties, mid-year formulary changes
  • Tax incentives for American production of pharmaceutical product, opioid taxes

Duration: to

General Issues: Trade (Domestic & Foreign), Pharmacy, Medicare/Medicaid, Taxation/Internal Revenue Code, Health Issues, Budget/Appropriations, Accounting, Science/Technology, Disaster Planning/Emergencies, Medical/Disease Research/Clinical Labs, Manufacturing, Labor Issues/Antitrust/Workplace, Copyright/Patent/Trademark

Spending: about $1,792,351 (But it's complicated. Here's why.)

Agencies lobbied since 2019: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), White House Office, Patent & Trademark Office (PTO)

Related Foreign Entities: Fresenius Kabi SwissBioSim GmbH (CH - 1262 Eysins, SUI); contribution to lobbying: $165532; ownership 100%; Fresenius SE KGA (Bad Homburg, GER); contribution to lobbying: $0; ownership 100%

Bills mentioned

H.R.3: Elijah E. Cummings Lower Drug Costs Now Act

Sponsor: Frank Pallone (D-N.J.)

S.1391: Fair Accountability and Innovative Research Drug Pricing Act of 2019

Sponsor: Tammy Baldwin (D-Wis.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Sarah D'Orsie Office of Congressman Tom Davis (R-VA), Professional Staff, House Government Reform and Oversight Committee
Sarah DOrsie Congressman Tom Davis
Tim Casey Office of Senator Tom Carper (D-DE) Office of Congressman John Tierney (D-MA) Congressman John Tierney Senator Tom Carper
Chase Walker Congressman Jodey Arrington

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Registration
Q2 Report
Q1 Report
Amendment
Q4 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page